Analysis of Downregulated Salivary Proteins in Oral Submucous Fibrosis - A Quantitative Proteomic Pilot Study

被引:0
|
作者
Babu, Anu [1 ]
Chatra, Laxmikanth [1 ]
Shenoy, Prashanth [1 ]
机构
[1] Yenepoya Dent Coll, Dept Oral Med & Radiol, Mangalore, Karnataka, India
关键词
Biomarker; malignant transformation; mass spectrometry; oral submucous fibrosis; proteomics; quantitative proteomic profiling; saliva; SQUAMOUS-CELL CARCINOMA; EXPRESSION;
D O I
10.4103/jiaomr.jiaomr_59_21
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Oral submucous fibrosis (OSMF) is a chronic debilitating disease of the oral cavity which is strongly associated with chewing of areca nut. The rate of malignant transformation varies between 3% and 19%. As oral lesions are in direct contact with saliva, the altered composition of saliva has shown promising results in surveillance of malignant transformation. Aim: To do quantitative proteomic profiling of saliva in OSMF and to study the downregulated proteins. Methodology: Quantitative proteomic profiling was carried out using Liquid chromatography with Tandem mass spectroscopy (LC-MS/MS) on saliva obtained from patients with OSMF. Results: A total of 172 proteins were identified in saliva samples. Five proteins were downregulated in the samples (fold change average of disease vs. control ratio <= 0.6). Conclusion: Downregulated proteins could serve as potential biomarkers in the early detection of malignant transformation in OSMF.
引用
收藏
页码:248 / 251
页数:4
相关论文
共 50 条
  • [21] Oral Submucous Fibrosis: A Study of Patient Profile
    Chatterji, Probal
    Mehrotra, Rohit
    [J]. INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY, 2014, 2 (08) : 139 - 143
  • [22] Quantitative Evaluation of Micronuclei in Oral Squamous Cell Carcinoma and Oral Submucous Fibrosis Patients: A Comparative Study
    Shah, Shreyas N.
    Manjunatha, Bhari S.
    Shah, Vandana S.
    Dagrus, Kapil
    Soni, Nishit
    Shah, Sanjiv
    [J]. RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2015, 10 (02) : 233 - 238
  • [23] Analysis of Iron Indices in Oral Cancer and Oral Submucous Fibrosis
    Prabhat, Kanika Bhalla
    Prabhat, Mukul
    Grover, Neeraj
    Singh, Shreya
    Bhandari, Shivani
    Sharma, Vandana
    [J]. JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 : 138 - 143
  • [24] Proteomic identification of cyclophilin A as a potential biomarker and therapeutic target in oral submucous fibrosis
    Yuan, Yao
    Hou, Xiaohui
    Feng, Hui
    Liu, Rui
    Xu, Hao
    Gong, Wang
    Deng, Jing
    Sun, Chongkui
    Gao, Yijun
    Peng, Jieying
    Wu, Yingfang
    Li, Jiang
    Fang, Changyun
    Chen, Qianming
    [J]. ONCOTARGET, 2016, 7 (37) : 60348 - 60365
  • [25] Differential expression of salivary S100A7 in oral submucous fibrosis
    Raffat, Muhammad Arsalan
    Hadi, Naila Irum
    Hosein, Mervyn
    Zubairi, Adnan Mustafa
    Ikram, Sana
    Akram, Zohaib
    [J]. SAUDI DENTAL JOURNAL, 2019, 31 (01) : 39 - 44
  • [26] PROTEOMIC ANALYSIS OF SALIVARY FLUID IN CYSTIC FIBROSIS
    Troxler, R. B.
    Mobley, J. A.
    Bowersock, G.
    Parrott, M.
    Roach, M.
    Sorscher, E. J.
    [J]. PEDIATRIC PULMONOLOGY, 2009, : 303 - 304
  • [27] Letter to the Editor: "Carcinogenesis of Male Oral Submucous Fibrosis Alters Salivary Microbiomes"
    Sarode, S. C.
    Sarode, G. S.
    Patil, S.
    [J]. JOURNAL OF DENTAL RESEARCH, 2021, 100 (05) : 557 - 557
  • [28] Evaluation of Salivary Opiorphin, pH and Flow Rate in Oral Submucous Fibrosis - A Case - Control Observational Study
    Varsha, K. S.
    Lakshmi, Krithika C.
    Ganesan, Anuradha
    Kannan, A.
    Aniyan, Yesoda K.
    [J]. JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2023, 15 : S656 - S660
  • [29] ANALYSIS OF CLINICAL SYMPTOMS IN PATIENTS WITH ORAL SUBMUCOUS FIBROSIS
    Poornachitra, P.
    Maheswari, Uma
    [J]. ANNALS OF DENTAL SPECIALTY, 2023, 11 (01): : 1 - 6
  • [30] Effectiveness of Antioxidants in Oral Submucous Fibrosis: A Retrospective Study
    Manivasagam, D.
    Muthukrishnan, A.
    Manjari, Chaudary
    [J]. ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH, 2021, 11